Cargando…

Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience

BACKGROUND: Transcatheter uterine artery embolisation (UAE) for the treatment of symptomatic fibroids has been performed in several centres in the United States, Western Europe and Asia with promising results. This study reports the authors' experience with UAE at the University Malaya Medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramaniam, RN, Vijayananthan, A, Omar, SZ, Nawawi, O, Abdullah, BJJ
Formato: Texto
Lenguaje:English
Publicado: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097770/
https://www.ncbi.nlm.nih.gov/pubmed/21611045
http://dx.doi.org/10.2349/biij.6.3.e27
_version_ 1782203887971729408
author Subramaniam, RN
Vijayananthan, A
Omar, SZ
Nawawi, O
Abdullah, BJJ
author_facet Subramaniam, RN
Vijayananthan, A
Omar, SZ
Nawawi, O
Abdullah, BJJ
author_sort Subramaniam, RN
collection PubMed
description BACKGROUND: Transcatheter uterine artery embolisation (UAE) for the treatment of symptomatic fibroids has been performed in several centres in the United States, Western Europe and Asia with promising results. This study reports the authors' experience with UAE at the University Malaya Medical Centre. METHOD: Fifty women with symptomatic uterine fibroids who declined surgery were treated by transcatheter UAE. The uterine arteries were selectively catheterised and embolised with polyvinyl alcohol particles. Post-procedure analgesia was administered via patient-controlled analgesic pump. The patients were followed up at an interval of 6/12 clinically and with MRI. RESULTS: Transcatheter UAE was performed on all 50 patients with no major complications. 49 patients had both uterine arteries embolised while 1 patient had only the right uterine artery embolised on account of hypoplasia of the left uterine artery due to previous myomectomy. The mean hospital stay was 3.5 days (range, 2 to 7). At a mean follow-up of 24/52, all patients reported improvements in their presenting symptoms. Objective improvement in terms of reduction of uterine and fibroid sizes was determined on MRI. One patient, who initially responded with a decrease in uterine and dominant fibroid size, became symptomatic (menorrhagia) after 6 months and subsequent endometrial sampling revealed cystic glandular hyperplasia for which total abdominal hysterectomy was performed. Two other patients had no change in symptoms and after hysterectomy, the pathology revealed concurrent adenomyosis. Another 2 patients with cervical fibroids were treated with hysterectomy as there was no gross reduction in the size of fibroid following UAE. Overall, 90% of the patients had dramatic improvement of anaemia and symptoms at 1 year follow-up. CONCLUSION: Out of the 50 patients, 17 patients had total disappearance of their fibroids and 28 patients had more than 50% reduction in the size of fibroids after 1 year. 5 patients ended up with total abdominal hysterectomy. These results suggest that UAE is an appealing alternative to hysterectomy or myomectomy for many women with symptomatic fibroids.
format Text
id pubmed-3097770
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
record_format MEDLINE/PubMed
spelling pubmed-30977702011-05-24 Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience Subramaniam, RN Vijayananthan, A Omar, SZ Nawawi, O Abdullah, BJJ Biomed Imaging Interv J Original Article BACKGROUND: Transcatheter uterine artery embolisation (UAE) for the treatment of symptomatic fibroids has been performed in several centres in the United States, Western Europe and Asia with promising results. This study reports the authors' experience with UAE at the University Malaya Medical Centre. METHOD: Fifty women with symptomatic uterine fibroids who declined surgery were treated by transcatheter UAE. The uterine arteries were selectively catheterised and embolised with polyvinyl alcohol particles. Post-procedure analgesia was administered via patient-controlled analgesic pump. The patients were followed up at an interval of 6/12 clinically and with MRI. RESULTS: Transcatheter UAE was performed on all 50 patients with no major complications. 49 patients had both uterine arteries embolised while 1 patient had only the right uterine artery embolised on account of hypoplasia of the left uterine artery due to previous myomectomy. The mean hospital stay was 3.5 days (range, 2 to 7). At a mean follow-up of 24/52, all patients reported improvements in their presenting symptoms. Objective improvement in terms of reduction of uterine and fibroid sizes was determined on MRI. One patient, who initially responded with a decrease in uterine and dominant fibroid size, became symptomatic (menorrhagia) after 6 months and subsequent endometrial sampling revealed cystic glandular hyperplasia for which total abdominal hysterectomy was performed. Two other patients had no change in symptoms and after hysterectomy, the pathology revealed concurrent adenomyosis. Another 2 patients with cervical fibroids were treated with hysterectomy as there was no gross reduction in the size of fibroid following UAE. Overall, 90% of the patients had dramatic improvement of anaemia and symptoms at 1 year follow-up. CONCLUSION: Out of the 50 patients, 17 patients had total disappearance of their fibroids and 28 patients had more than 50% reduction in the size of fibroids after 1 year. 5 patients ended up with total abdominal hysterectomy. These results suggest that UAE is an appealing alternative to hysterectomy or myomectomy for many women with symptomatic fibroids. Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2010-07-01 /pmc/articles/PMC3097770/ /pubmed/21611045 http://dx.doi.org/10.2349/biij.6.3.e27 Text en © 2010 Biomedical Imaging and Intervention Journal http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Subramaniam, RN
Vijayananthan, A
Omar, SZ
Nawawi, O
Abdullah, BJJ
Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience
title Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience
title_full Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience
title_fullStr Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience
title_full_unstemmed Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience
title_short Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience
title_sort uterine artery embolisation for symptomatic fibroids: the university of malaya medical centre experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097770/
https://www.ncbi.nlm.nih.gov/pubmed/21611045
http://dx.doi.org/10.2349/biij.6.3.e27
work_keys_str_mv AT subramaniamrn uterinearteryembolisationforsymptomaticfibroidstheuniversityofmalayamedicalcentreexperience
AT vijayananthana uterinearteryembolisationforsymptomaticfibroidstheuniversityofmalayamedicalcentreexperience
AT omarsz uterinearteryembolisationforsymptomaticfibroidstheuniversityofmalayamedicalcentreexperience
AT nawawio uterinearteryembolisationforsymptomaticfibroidstheuniversityofmalayamedicalcentreexperience
AT abdullahbjj uterinearteryembolisationforsymptomaticfibroidstheuniversityofmalayamedicalcentreexperience